A Review: Progress of Prevention and Control on Viral Hepatitis in China

Biomedical and Environmental Sciences

Volumn 12, Issue 3, 1999, Pages 227-232

  Guo, Xiu Chan ^a   Wu, Yi Qun ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHINA; ECONOMICS; HEALTH CARE COST; HUMAN; PUBLIC HEALTH; RISK FACTOR; VIRUS HEPATITIS;

CHINA; HEALTH CARE COSTS; HEPATITIS, VIRAL, HUMAN; HUMANS; PUBLIC HEALTH; RISK FACTORS;

EID: 0033181782     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Alter, M. J. (1997). Epidemiology of hepatitis C. Hepatology 26, 62s-5s.
2. Cai Yihua, Fang Shunyuan, Wang ZHiqiang, et al. A Sero-epidemiological study on HGV infection in HCC patients. Disease Surveillance 13(5), 167.
3. Cao Huilin, Jia Zhiyuan, Liu Chongbai, et al. (1998). A long-term observation on HBsAg positive status of the children vaccinated at the birth time with hepatitis B vaccine. Chinese Journal of Vaccines and Immunization 4 (6), 353. (in Chinese)
4. CDC (1998). Hepatitis C. In Division of VIral and Rickettsial Diseases Program Reviews and Plans, p. 79.
5. CDC (1991). Public health service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR 40 (No. RR-4), 1.
6. Dai Zhicheng and Qi Guoming (1997). Virus Hepatitis in China, Sero-epidemiological Survey in Chinese Population (Part one), 1992 - 1995. Press of Science and Technology Document, (in Chinese)
7. Damme, Van P, Meheus, A, and Kane, M. (1998). Concluding remarks. Vaccine. 16, S109.
8. Department for Disease Control, Ministry of Health, China (1999). Development of Hepatitis B Vaccination. A Collection of Documents of a Seminar on Management of National Immunization Programme, (in Chinese)
9. Huang Zhaoneng, Chen Xiurong, Li Rongcheng, et al. (1998). An evaluation on 10 years effectiveness of large-scale hepatitis B vaccination in neonates. Disease Surveillance 13, 247. (in Chinese)
10. Huang Zuolin, Li Jun, Wu Jinan, et al. (1998). A serological survey of HBV infection rate in 3-5 years old children born before and after the implementation of EPI. Chinese Journal of Vaccine and Immunisation 4, 222. (in Chinese)
11. Idilman, R, Maria, N. De, Colantoni A, et al. (1997). Interferon treatment of cirrhotic patients with chronic hepatitis C. Journal of Viral Hepatitis 4, 81.
12. Li Hui, Li Rongcheng, Liao Shushu, et al. (1998). Long-term efficacy of hepatitis B vaccination in infants in Zhuang Minority Area. Disease Surveillance 13, 45. (in Chinese)
13. Linnen, J, et al. (1996) Molecular cloning and disease association of hepatitis G virus: A transfusion transmisible agent. Science. 27, 505.
14. Mark A. Kane (1998). Status of hepatitis B immunization programmes in 1998. Vaccine 16, S104.
15. Mark A. Kane (1998). Status of hepatitis B immunization programmes in 1998. Vaccine 16, S104.
16. Tong Zhifu and Zhang Jianlin (1998). Infection of hepatitis C in hospital. Disease Surveillance 13, 308. (in Chinese)
17. Wang Zao (1999). Raising Recognition and Strengthening Achievement of Expanded Programme of Immunization, Meeting the Challenge and Promoting Devlopment of Immunization Programme. A Seminar on Management of National Immunization Programme, (in Chinese)
18. World Health Organization (1992). Expanded Programme on Immunization, Global Advisory Group. Week Epidemiol Record 3, 11
19. Zeng Pin, Zhang Qinglian, Zhao Qiyun, et al. (1998). Investigation on immuno-efficacy of recombinant hepatitis B vaccine. Disease Surveillance 13, 418. (in Chinese)
20. Zhuang Hui (1997). Strengthening prevention and control Viral Hepatitis. Conference on Prevention of New Infective Diseases. (in Chinese)